Quote on Glenmark Life Sciences IPO Listing by Mr. Vinod Nair, Geojit Financial Services
Below is quote on the Zomato IPO listing by Mr. Vinod Nair, Head of Research at Geojit Financial Services.
"Given its strong focus on R&D expansion plans, leadership in select high-value non-commoditized APIs in therapeutic areas, solid clientele and growth opportunities in CDMO services provide a strong outlook for the company. At the upper price band of Rs.720, GLSL is available at a P/E of 25x (diluted) which appears fairly priced. Considering its robust growth in financials, fall in D/E, rise in future capacity and future product portfolio, the stock can be considered on a long-term basis"
Above views are of the author and not of the website kindly read disclaimer
Top News
RBI Sees Q4FY22 GDP Growth at 6.1%
Tag News
We anticipate immense potential benefits from the upcoming Sovereign Gold Bond Tranche in FY...